Mindray Acquires Datascope’s Medical Monitor Business
This article was originally published in PharmAsia News
Executive Summary
Shenzhen Mindray Bio-Medical Electronics will acquire its American partner Datascope's medical monitor business for $202 million, making Mindray the third biggest global brand in the field after Philips and GE. The buyout includes Datascope's R&D of medical monitor devices, production, sales and relevant intellectual property rights. Mindray will continue to use the Datascope brand until 2015 and will take advantage of Datascope's direct distribution channel to facilitate product entry into European and American hospitals. In addition, Mindray plans to outsource Datascope's R&D to its team in China for greater competitiveness. (Click here for more - Chinese Language)